L. Martinez-martinez et al., Roles of beta-lactamases and porins is activities of carbapenems and cephalosporins against Klebsiella pneumoniae, ANTIM AG CH, 43(7), 1999, pp. 1669-1673
Two clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing
Klebsiella pneumoniae were noted to be less susceptible than expected to im
ipenem. Both were missing outer membrane proteins that serve as channels fo
r antibiotic entry. The role of beta-lactamase in resistance was investigat
ed by eliminating the original ESBL and introducing plasmids encoding vario
us ESBLs and AmpC beta-lactamase types, by studying the effect of an increa
sed inoculum, and by evaluating interactions with beta-lactamase inhibitors
. The contribution of porin deficiency was investigated by restoring a func
tional ompK36 gene on a plasmid. Plasmids encoding AmpC-type beta-lactamase
s provided resistance to imipenem (up to 64 mu g/ml) and meropenem (up to 1
6 mu g/ml) in strains deficient in porins. Carbapenem resistance showed lit
tle inoculum effect, was not affected by clavulanate but was blocked by BRL
42715, and was diminished if OmpK36 porin was restored, Plasmids encoding
TEM- and SHV-type ESBLs conferred resistance to cefepime and cefpirome, as
well as to earlier onyimino-beta-lactams. This resistance was magnified wit
h an increased inoculum, was blocked by clavulanate, and was also lowered b
y OmpK36 porin restoration. In addition, SHV-2 beta-lactamase had a small e
ffect on carbapenem resistance (imipenem MIG, 4 mu g/ml, increasing to 16 m
u g/ml with a higher inoculum) when porins were absent. In K. pneumoniae po
rin loss can thus augment resistance provided either by TEM- or SHV-type ES
BLs or by plasmid-mediated AmpC enzymes to include the latest oxyimino-beta
-lactams and carbapenems.